MitoTEMPO mitigates light-induced retinal degeneration and photoreceptor ferroptosis in Abca4-/-Rdh8-/- mice via inactivating the KEAP1/NRF2/HO-1 signaling pathway. The gene discussed is NFE2L2; the disease is retinal degeneration.